Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rashmi Chugh
University of Chicago Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Joliet Oncology-Hematology Associates Limited
Joliet, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Mercy Hospital Saint Louis
St Louis, Missouri, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 31 Jan 2013
- Completion
- —
- Last update posted
- 17 May 2016
- Registered enrollment
- 30
- Registry id
- NCT00720174
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.